Malaysia approves Sinovac COVID-19 vaccine for ages 12 to 17
Updated 2021.10.01 17:00 GMT+8
CGTN
Malaysian regulators announced conditional approval on Friday for Chinese pharmaceutical company Sinovac Biotech's CoronaVac COVID-19 vaccine for use in those aged between 12 and 17.